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Platelet Size in Man
By Jean-Michel Paulus
The shape and parameters of platelet size
distributions were studied in 50 normal
persons and 97 patients in order to test the
proposed thesis that platelet size hetero-
geneity results mainly from aging in the
circulation. This thesis was contradicted
(1) by size distributions of age-homog-
eneous, newly-born cell populations
which were lognormal with increased (in-
stead of decreased) dispersion of volumes
and (2) by the macrothrombocytosis
found in some populations with normal
age distribution. For these reasons, throm-
bocytopoiesis appeared to play the major
role in determining platelet size. A model
was built in which the volume variation of
platelet territories due to megakaryocyte
growth and membrane demarcation at
each step of maturation was a random
proportion of the previous value of the
volume. This model explains the lognor-
mal shape of both newborn and circulat-
ing platelet size distributions. It also
implies that (1) the mean and standard
deviation of platelet logvolumes depend
on the rates of volume change of the in-
dividual platelet territories (growth rate
minus demarcation rate) as well as on
megakaryocyte maturation time; (2)
platelet hyperdestruction causes an in-
crease in the mean and dispersion of the
rates of territory volume change; (3) Med-
iterranean macrothrombocytosis and some
hereditary macrothrombocytotic thrombo-
cytopenias or dysthrombocytopeieses re-
flect a diminished rate of territory
demarcation, and (4) platelet size hetero-
geneity is caused mainly by the variations
in territory growth and demarcation and
not by aging in the circulation.
S TUDIES OF CIRCULATING platelets indicate that these cells are
markedly heterogeneous in size,’-6 density,3’7-9 and metabolic, functional,
and biochemical properties.3’7”#{176} It has been suggested that this heterogeneity
results from aging in the circulation and that young platelets are larger, denser,
and more active than the older ones.3,lbo Thus, disorders involving an increased
proportion of young platelets, because of hyperdestruction or a sudden release
of newly produced cells, would normally be accompanied by macrothrombo-
cytosis. In fact, such is the case in idiopathic thrombocytopenic purpura
(ITP),”-’5 although opposite opinions have been expressed,’6 in systemic lupus
erythematosus, certain drug-induced thrombocytopenias, disseminated intra-
vascular coagulation,’4 the hereditary macrothrombocytopathy of the Bernard-
Soulier syndrome,’7-’9 and the regeneration phase following experimentally in-
duced throm bocytopenia 2,9,3,20-23
However, in the disorders listed above, changes in thrombocytopoiesis also
occur, and it is therefore possible that altered platelet production plays a role
in the genesis of macrothrombocytosis. Macrothrombocytosis has also been
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associated with normal platelet survival in certain hereditary disorders,’5￿27
indicating that factors other than the percentage of young platelets determine
platelet size distributions. Similar conclusions have been drawn from animal
experiments9 and from the microthrombocytosis associated with the Wiskott-
Aldrich syndrome’5’28 in which platelet life span is reduced.28 It is the purpose of
this paper to investigate the role and nature of the megakaryocytic mechanisms
involved in the determination of platelet size. The shape and parameters of
size distribution in normal subjects were therefore compared with those of pa-
tients with macrothrombocytosis having reduced or normal platelet survival.
MATERIALS AND METHODS
Blood samples (3.3 ml) for determination of platelet volume distribution (PVD) were col-
lected in 4-mI, internal diameter 10 mm, Vacutainer tubes (Becton-Dickinson, Rutherford, N.J.)
containing 0.7 ml acid-citrate dextrose solution (ACD, USP, formula A, Fenwall Laboratories,
Morton Grove, Ill.) from 50 normal persons and 97 patients. The tubes were kept at 37#{176}C,
and studies were performed within 2 hr. Preliminary studies showed that this procedure main-
tained constant platelet shape, PVD, and count. Specimens kept at room temperature for up to
1 hr could also be used provided they were incubated for 1 hr at 37#{176}C before size measurement.
Incubation at 4#{176}C was not satisfactory, since cold temperature caused the amplitude of plate-
let pulses to increase29 because of volume and/or shape changes.
Microscopic Determinations of Size Distribution
Two techniques for determination of size distribution were used. (1) Platelets in ACD blood
samples were sized after smearing on glass slides and staining with the May-Grtlnwald-Giemsa
method. Diameters were measured with a 100 x objective and a calibrated screw-micrometer
fixed on a 8 x eyepiece (Zeiss, Oberkochen, Germany, catalog No. 46 3972; one division in the
micrometer represented 0.1 Mm). The surface was calculated from the average of two diameter
measurements. (2) Platelets in platelet-rich plasma (PRP) prepared from EDTA blood specimens
were measured as a vital preparation on a glass slide by use of a phase-contrast microscope and
the same screw-micrometer as above. Under these conditions, platelets were spherical, and their
volumes could be calculated from the diameters. The optical system comprises a 40 x objective
and a 2 x magnifying glass so that each division corresponded to 0.117 Mm. All measurements
were made within 15 mm after blood collection.
Preparation of Platelet Suspensions for Electronic Counting and Sizing
Platelet-rich plasma (PRP) was prepared by centrifugation of the Vacutainer tube in a table
centrifuge for 25 sec at 40 g (800 rpm) according to the method of Bull.30 A plastic head
holding the tubes vertically and with a capacity of 20 tubes was build in order to keep the ac-
celeration applied to the sample independent of the height of the blood column, i.e., of the
sample volume; this device made it possible to prepare a reproducible PRP whether or not
blood had been drawn previously from the tube for red and white cell measurements with the
Coulter Counter Model S. The final platelet suspension was prepared from PRP by diluting
6.6 Ml of PRP in 20 ml of Isoton (Coulter Electronics, Hialeah, Fla.). In order to verify that
size distributions were not affected by centrifugation at 40 g, platelet surface distributions on
smears (see below) were compared in the original uncentrifuged blood sample and in the PRP. No
significant change in shape or parameters of the distribution was observed in four experiments
using samples from normal subjects or patients with macrothrombocytosis.
In one experiment, platelets were rounded by addition to the PRP of 0.04 g/ 100 ml pro-
methazine ￿ The cells were then incubated from 3 to 30 mm at 37#{176}C and diluted
in Isoton as above.
Platelet Counting.
Platelet counting was performed from Isoton suspensions prepared from EDTA or ACD sam-
ples using the Coulter Counter method of Bull, Schneiderman, and Brecher.32 The hematocrit
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was measured with the Coulter Model S. For patients with platelet volumes higher than 15
cu Mm, the usual discriminator settings were invalid, and the count was verified by phase-con-
trast microscopy.
Electronic Determination of Platelet Size Distribution
A model Coulter Counter, model F (using a 7O-￿m aperture; attenuation and current intensity
settings were ￿), was connected to a 400-channel analyzer (Model SA4OB, modified to analyze
pulses with maximum rising time of 50 Msec: Intertechnique, Plaisir, France) according to Le Go,
Le Go, and Crouill#{232}re.33 In conditions where particle shape, electrolyte resistance, dcc-
Fig. 1. Frequency (A) and log-frequency (B) distributions of volumes, as well as frequency
distribution of Iogvolumes (C) in platelets from a normal subject. The abscissa covers a range
of 0-22 cu ￿m. Platelet Iogvolumes have a bell-shape, symmetric distribution, suggesting
normal distribution. On a logarithmic ordinate, the descending slope of the volume distribution
is approximately linear.
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tronic amplification and capillary aperture diameter were kept constant, the Coulter Counter pro-
duced electrical impulses whose amplitude was proportional to the volume of the individual
particles passing through the aperture. The channel analyzer recorded a 100-200 class histogram
of the pulse amplitudes produced by platelet particles. Determinations made with calibrated
latex particles (3.423 cu Mm) showed that corrected mean channel number (mean channel num-
ber x amplification factor) was linearly related to particle volume. No correction of PVD for
particle concentration was made, since nearly identical curves were recorded from suspensions con-
taining from 59,000 to 680,000 platelets per ml. The counting was discontinued when the channel
corresponding to the modal (peak) volume contained 4000 counts (the total number of pulses
counted was about 100,000).
Probit Plots of Platelet Size
In order to study the shape of platelet size distributions, probit plots of cumulative frequency
versus size parameters were made from the microscopic or electronic determinations. The latter
often had to be truncated at the upper end of the spectrum because of red cell contamination.
It was then necessary to correct the experimentally obtained total platelet count. This was done
by using the empirical finding that the frequency count in the second half of the volume distribu-
tion decreased approximately exponentially with the channel number (Fig. 1). The corrected,
absolute count in the sample was
Z =￿ X￿ + [X,￿. h/0.693J
where X3 was the count in channel3 and h the number of channels associated with halving of the
count per channel. The probit plots were then drawn for the range 0 to 22-27 cu Mm, excluding
the truncated fraction.
Computation of Size Parameters
As will be shown later, nearly all platelet volume distributions so far studied were compatible
with the lognormal model, i.e., platelet logvolumes were normally distributed. Since logarithmic
transformation of the Coulter pulses was not available until recently, the following formula was
used to convert the original volume distribution into a logvolume curve with constant class width:
fi￿￿ =f￿x￿/1￿2
where fe,, ￿ and f￿ represent the relative frequency in the classes In x with width L 1 and x with
width L2, respectively. L1 and L2 were calibrated daily and varied by about 5% during a 1-yr
period. Typical values were 0.027 (logvolume units) and 0.21 cu ￿m, respectively.*
The logvolume distribution of the Coulter pulse amplitudes was influenced by both electronic
and particle contamination at the lower range of the curve and by small erythrocytes at the higher
end. These artifacts prevented the calculation of absolute platelet size values from the usual
formulae relating the mean and standard deviation to particle frequency in the various classes.
This difficulty was overcome by using Bhattacharya’s technique34 (Fig. 2). A normal distribution,
such as that of logvolumes, can be described by an equation of the form F = w.exp (bz2). Hence,
In F,08￿0, = In w + bz2 is a parabola, and the derivative of the latter equation is d(ln F ogvol )/dz =
2 bz, indicating that the differences of the logfrequencies in the lognormal distribution can be
fitted by a straight line (Fig. 2). It can further be shown that this line crosses the logvolume
abcissa at the mean logvolume estimate plus one-half the channel width and has a slope very
* Because these standards were inert spherical particles which differed in shape and membrane
properties from platelets, the size values do not represent absolute estimates. The mean and stan-
dard deviation of volumes determined after calibration with red cells were 37% greater, i.e., log-
volumes were increased by 0.31 unit.
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tThe subscripts L and V will be used in the symbols of size parameters to designate the log-
volume (14 and volume (V) distributions. For instance, ML’ t￿v represent the mean of the log-
volume and volume distributions and 6L and by, the corresponding standard deviations. Other
symbols are explained in Table 1. All logarithms used are Naperian.
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Fig. 2. Determination of mean and standard deviation of logvolumes by the computer methed
described in the text. The top panel has a linear volume abcissa, while the lower panel has a
geometric scale for the abcissa. In beth graphs, the total range covers 26.47 cu ￿m. The vertical
lines indicate the limits from 3.5 to 15 cu ￿m between which background and red cell pulses do
not influence the curves. Because of the change in scale, these limits correspond to channels 16 and
69 in the top panel and 45 and 99 in the lower one. The volume distribution recorded in the
channel analyzer, which has a constant volume class interval, is converted into a straight line
using the conversion of the ordinate explained in the text. The regression line reaches the zero
ordinate at the median volume, whose logarithm is the mean Iogvolume Mt, and the slope is in-
versely propertional to the variance of logvolumes #{244}￿.
close to -L 1/S￿, where 5L is the logvolume standard deviation.t In this analysis, distinct pulse
populations may appear as separate lines in the graph of logfrequency differences. Using channel
limits corresponding to 3.5 and 15 cu Mm, it was possible to delineate a region where platelet
pulse distribution was not influenced by electronic or particle contamination. The differences of
the logfrequencies for about 50 classes in the above interval were therefore entered into a linear
regression subroutine. From the estimates of ML and #{212}L obtained, the parameters of the original
volume distribution were then computed (Table I). The thrombocytocrit (ml of platelets per 100
ml of total blood) was calculated as the product of platelet count and volume.
The validity of this mathematical analysis was demonstrated in the mean volume range 4.5-20
cu Mm as follows: (1) In seven cases where contamination at both￿ ends of the curve was minimal,
M v and 6 v were calculated by both the present and standard methods. The results differed on the
average by 0.9% (Mv) or 6.4% (by). (2) Forty different lognormal distributions with ML = 1.5 to
2.4 and 6L = 0.5 to 1.2 were simulated on a 1800 IBM computer according to Aitchison and
Brown.35 To each simulated volume distribution, a background distribution measured for 1 mm
on a day of usual laboratory activity was added. The simulated values were then used as data for
the size parameter calculations described above. It was found that the calculated values were closely
correlated with those expected (r varying between 0.96 and 0.99), although there was a small
systematic error, reflected by the value of the ordinate at the origin of the regression equation
between expected and recorded values (Table 1). (3) The influence of red cell contamination was
assessed by adding various volumes of Coulter Counter Cell Control (4C, Coulter Electronics) to
a platelet suspension in Isoton. Red cell contaminations of 3.5%, 15.6%, 23.5%, and 40.1% caused
no significant variation of Mv and by (coefficient of variation of the four determinations was 2.5%
for i￿v and 2.7 for by). (4) The reproducibility of the method in normal subjects is also
given in Table 1 and shows that a reproducible estimate can be obtained for most parameters. The
greatest variability was observed for by.
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eln this study, mean life span refers, as usual, to mean life expectancy of newly born cells
whereas mean age refers to the circulating population.
Table 1. Size Pam meters in Normal Subjects
DefInitions Normal Values#{176}
Accuracy of
Mathematical Analysist CV of Repeated Determinationst
Size
Parameter Symbol Mean 95% Limits
Equation Recorded
vs. Expected Value r
On One On One On One
Suspensioni Blood Sample I) Patients
Logvolume distribution (L)
Mean
SD 6￿
CV K￿ - lOOp￿/t￿
1.68 1.38-1.86
0.61 0.50-0.74
36.0 29.8-4.4.5
y - -0.08+ l.02X 0.99
y - 0.04 + 0.98 X 0.98
y - 1.32 + 1.03 X 0.97
1.6 2.5 2.5
3.5 3.4 8.4
4.4 4.5 9.0
Volume distribution (V)
Mean - exp(pL + 0.56?)
SD tv - (tiy Kv)/100
CV Ky - 100(exp(t?)- 1)
Median Med￿ - exp(pL)
Mode MOdv - exp(pL -
6.6 4.8-8.5
4.3 3.1-7.2
66.0 53.8-86.8
5.4 4.0-6.4
3.7 2.8-4.6
y - -0.16+ 1.02X 0.98
y - 0.34 + 1.15 X 0.96
y - 3.22 + 1.02 X 0.96
y - -0.19 + 0.99 X 0.99
y - -0.05 + 0.93 X 0.99
2.1 4.1 5.2
4.2 6.5 14.0
3.9 4.1 10.2
2.5 4.1 4.1
4.3 5.1 9.2
#{176}Resultsofdeterminations made in 50 laboratory personnel.
tAccuracy of mathematical estimation was determined by calculating the regression equation and correlation coefficient of recorded (y)
versus expected (x) value of the parameter, using simulated volume distributions as described in text.
1CV, coefficient of variation (100 times SD of experimentol results divided by mean).
§Eighl determinations made from one platelet suspension in Isoton.
I)Eight determinations made tram one 50-mI blood sample divided into eight tubes. PRP was obtained from each tube by separate cen-
trifugation and diluted in Isoton as described in Materials and Methods.
11 Eight determinations made in a 15-day period in one normal subject.
Deflni:ions, normal values, and errors of determination of size parameters measured in suspensions of normal platelets using ACD blood.
Equations relating the parameters in the volume distribution to the mean p￿ and SD t￿ of the logvolume distribution are shown in the second
column. All volumes are expressed in cubic micrometers. Naperion logarithms are used in all cases. The calibration was made by means of
latex particles measuring 3.42 cu pm. Because these standards differ in shape and membrane properties from platelets, the size values do not
represent absolute estimates. The mean and standard deviation of volumes determined after calibration with red cells were 37% greater, i.e.,
logvolumes were increased by 0.31 unit.
Determination of Platelet Survival
Samples of the circulating platelet populations were labeled with 5tCr by use of the acid-
citrate method36 and injected into ten normal persons and 28 patients in order to correlate the
survival and size parameters. Autologous platelets were used in all cases. In all patients with
macrothrombocytosis, whole-blood samples were used as an index of platelet survival in order to
avoid the loss of large platelets during platelet isolation procedures. In all the cases reported
here, red cell-bound 51Cr activity injected was less than 2.5% of the total platelet activity in-
jected. The survival data 5(t) (i.e., the proportion of injected activity remaining in the circulation
at times varying from 30 mm to a time corresponding to zero activity) were fitted to a polynomial
regression using a program written for a 360/50 IBM computer. From the best fit survival equation
S(t) = c(0) + c(l)t + c(2)t2... + c(n)t”, platelet mean life span* could be computed as q =
-c(0)￿c(l),37 and the mean age of circulating platelets was calculated as the area under S(t)/
S(0).3 Previous studies using simulated survival data with known mean life span and age
showed that this method gave an accurate estimate (error less than 10%- 15%) of the survival
parameters.39 Furthermore, in all the cases reported here, repeated platelets counting in the
days preceding platelet separation and transfusion showed no significant change which could pre-
clude the use of the above formulae.39 For short survivals (q less than a day), however, the
best results were obtained when the logarithms of survival data, rather than the survival data
themselves, were entered into the polynomial regression program. In all the cases of short survival
studied here the logarithms of activity could be fitted by a first-degree polynomial, and both the
mean life span and age were equal to - l/c(1).
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RESULTS
Distribution of Platelet Sizes in Normal Subjects
When sized by the electronic method, circulating platelets of 50 control labo-
ratory personnel had a unimodal, positively skewed distribution of volumes
(Fig. 1). However a bell-shape, symmetrical curve was obtained when the fre-
quency distribution of logvolumes was recorded either by interfacing a loga-
rithmic amplifier between the Coulter Counter and the analyzer (Fig. 1) or by
converting the original volume curve as described above. Furthermore, a linear
relationship could be demonstrated between the differences of the logfre-
quencies and the corresponding logvolumes (Fig. 2) or between the probits
corresponding to the cumulative frequencies and the logvolumes (Fig. 3). These
results suggested that platelet logvolumes were normally distributed, i.e., that
platelet volumes had a lognormal distribution.
The shape characteristics of platelet size distribution did not depend on the
procedure used. The probit graph was not influenced by the dimensions of the
aperture between 30 and 70 ￿tm (Fig. 3), by particle concentration (from 50,000
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FIg. 3. Lognormal distribution of platelet sizes in normal subjects. The cumulative frequencies
are plotted on a Gaussian probability scale against the logarithms of volume (Iogvolumes). The
curves have been displaced relatively to each other to facilitate comparison of shape. Each inter-
val in the abcissa corresponds to an increase of Iogvolume or logsurface of 1.0 U, i.e., to an in-
crease in volume or surface by a factor of 2.781. In experiments (A-C) sizes were determined by
the Coulter Counter channel analyzer methed. (A) One single suspension was measured with
Coulter aperture tubes having diameters and lengths (Mm) equal to 70 x 84; 70 x 56, 50 x 50,
and 30 x 45, respectively. (B) Comparison between control discoid platelets and platelets sphered
with promethazine. (C) Curvilinear graph obtained with mixed suspensions of normal (mean
volume, 8.0 cu Mm) and macrocytic (13.8 cu Mm) platelet populations. (D) and (E) Distributions
obtained from microscopic measurements of diameters on suspensions (D) or smears (E) (see
Materials and Metheds). (0) represents Iogvolume distributions from ten normal subjects. (E) are
the Iogsurface distributions of normal platelets measured in smeared plasma or blood. The log-
normal distribution of sizes is demonstrated by the linear curve obtained in all experiments ex-
cept in the suspension mixture shown in (C).
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to 400,000/mi), or by platelet shape (discoid in ACD-PRP or spherical after
incubation of PRP with 0.04 g/lOO ml of promethazine hydrochloride for 3-30
mm) (Fig. 3). However, in contrast to the linear shape recorded in cases where
a single platelet population was analyzed, a curvilinear probability plot was
obtained with suspensions containing approximately equal numbers of control
(mean volume, 8.0 cu tim) and macrocytic (mean volume, 13.8 cu ￿zm) platelets
(Fig. 3).* In order to verify that the distribution properties were not caused by
electronic artifacts, probability plots were drawn from cumulative frequency
curves obtained by the microscopic method. Linear plots were recorded for
logdiameters or logvolumes of platelets in suspension and for logdiameters and
logsurfaces of cells spread on smears (Fig. 3).
Finally, it was also demonstrated that the unimodal shape of the distribu-
tion was not due to a selective loss of cells during preparation of PRP, since
in experiments made with four different specimens, including one with macro-
thrombocytosis, a linear plot was obtained microscopically both from the PRP
and the initial blood sample (Fig. 3). Although slight differences in mean and
standard deviation existed between PRP and blood samples, these did not show
any constant trend and appeared to depend essentially on differences in spread-
ing on glass.
The finding that PVDs are lognormal justifies the mathematical analysis
described above. Lognormal distributions can be characterized by the eight
parameters defined in Table 1, which include the mean ￿t, standard deviation #{244}￿
and coefficient of variation K in both the logvolume (subscript L) and volume
(subscript V) distributions, plus the median and mode in the PVD. The values
obtained in 50 normal laboratory personnel are given in Table 1, together with
the 95% limits that were used as reference standards for patient studies.
Macrothrombocytosis in Cohorts of Young Platelets
Macrothrombocytosis in cohorts of young platelets could be studied in two
clinical situations: (1) in 20 patients with stable platelet counts whose platelet
life spans were less than 3 days and whose mean platelet age was generally well
under 3 days (stationary hyperdestruction). The platelet count varied from
10,300 to 310,000/cu mm. This group included 11 cases of ITP, six cases of
systemic lupus erythematosus, two cases of malignant lymphoma, and one case
of uncertain etiology; (2) in five patients with rapidly increasing platelet counts,
including three patients whose platelet counts rose from under 10,000/cu mm to
189,200, 153,400, and 184,000, respectively, in less than 24 hr following splenec-
tomy for ITP; two patients whose counts had fallen from normal values to
3000 and 14,500/cu mm, respectively, after treatment with mechloretamine
(for esophageal carcinoma) and cyclophosphamide plus amethopterine (for
bronchial carcinoma) and rose again to 835,000 and 600,000/cu mm in 7 and
10 days, respectively.
*The addition of the macrocytic sample, which contained 35.5% megathrombocytes (platelets
with volume greater than 13 cu Mm) increased the megathrombocyte index of the control sample
from 12.1% to 23.8%. It appeared that such a small increase in the percentage of large platelets
was detectable by the probit plots (Fig. 3).
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Fig. 4. Lognormal distribution of platelet sizes in ￿
cohorts of young platelets using the same coordinates
as in curves (A-C) of Fig. 3. Because of red cell con- ￿ 95
tamination, the upper end of the curve was truncated, ￿ go
and the total count was corrected as described in ￿
Materials and Methods. (A) refers to regenerating ￿ 75
platelets from three subjects splenectomized for ITP #{176}
whose platelet count rose from less than 10,000/cu ￿ so
mm to 189,000, 153,400, and 184,000/cu mm in less ￿
than 24 hr. Mean platelet age was 10-12 hr. (B) ￿ 25
refers to young platelets from patients with platelet ￿
hyperdestruction whose platelet mean age was less ￿ 10
than 1 day and whose platelet count ranged from i s
10,000 to 75,000/cu mm. All distributions were com- )
patible with lognormality except the first one, which ￿
showed slight deviations from linearity on the log-
arithmic probability scale.
In both groups, linear plots were recorded on probability graphs relating the
cumulative frequency to the corresponding logvolume (Fig. 4). However, the
upper tail of these curves could not always be analyzed because of truncation
due to red cell pulses. For this reason, the cumulative percentages from 1%
to 93%-99% were plotted, omitting the values above. In these conditions a
slight deviation from linearity was recorded in only one postsplenectomy ex-
periment, (second curve in A, Fig. 4), presumably because the suspension con-
tained a mixture of changing populations.
In both groups, the size parameters were clearly related to platelet count,
the greatest changes being found in the most thrombocytopenic patients. In
these patients, the size profile of the circulating platelet population consisted
of increased mean, median, and modal logvolumes and volumes, together with
increased dispersion of volumes. Results obtained in the 20 patients with sta-
tionary hyperdestruction are shown in Fig. 5. There was a highly significant
negative correlation between platelet count and volume (r = -0.51, p < 0.001)
or standard deviation of volumes (r = -0.52, p <0.001).
Macrothrombocytosis With Normal Platelet Age Distribution
Macrothrombocytosis with normal platelet age distribution was found in the
seven subjects described in Table 2 whose size parameters are shown in Fig. 5.
Subjects 1-5 presented the recently described Mediterranean macrothrombo-
cytosis4#{176}together with various nonhematologic diseases, except for case 5 who
had liver cirrhosis with palpable splenomegaly. No patient had erythrocyte
macrocytosis or marrow megaloblastosis. All had moderate thrombocytopenia
(86,400-138,300 platelets/cu mm), moderately to greatly increased platelet
volume (11.5 to more than 20 cu ￿tm), normal thrombocytocrit (0.10-0.23
ml/100 ml), and near-normal or normal platelet life span (5.5-9.4 days) and
age (3.6-5.1 days) (Fig. 6). When their mean volumes and standard deviation
of volumes were plotted against platelet count, these five subjects formed a
group quite distinct from those with hyperdestruction. The son of patient 3,
who had no survival study, presented a slightly different picture, including
normal platelet count (216,000/cu mm), macrothrombocytosis (13.18 cu .tm),
and borderline thrombocytocrit (0.29 ml/100 ml).
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a. Fig. 6. Survival studies in subjects
FARI, RUSS, and PACF, whose kinetic and
size parameters are described in Table 2.
The normal platelet survival and age in
these three patients indicate that macro-
thrombocytosis was not caused by ele-
vated percentage of young platelets.
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Table 2. Platelet Kinetic and Size Parameters
Volume Survival
Logvolume Distribution
Thrombo- Distribution Mean SD CV Median
Parameters
Mode Life Mean
Counf cytocrit Mean SD CV ii., #{244}￿ Kr Medr Mod￿ Span Age
(perMl) (mI/lOOmI) Mt tSt K￿ (cu/Lm) (cuMm) (%) (cuMm) (cupm) (days) (days)
Mediterranean macrothrombocytosis
CUSU 90,800 0.23 2.72 0.99 36.3 25.0 32.2 129.0 15.3 5.7 5.5 3.6
MICE 125,000 0.22 2.51 0.84 33.5 17.7 18.1 102.1 12.4 6.1 7.4 4.3
FARI 109,300 0.14 2.45 0.82 33.7 16.3 16.2 99.1 11.6 5.9 6.4 4.3
PACF 138,300 0.23 2.47 0.81 32.8 16.5 16.0 96.7 11.9 6.1 9.4 5.1
RUSS 86,400 0.10 2.19 0.70 32.2 11.5 9.2 80.4 9.0 5.4 6.0 4.0
Dysthrombocytopoiesis
TASI 388,800 0.38 1.96 0.79 40.6 9.8 9.3 94.5 7.1 3.8 5.8 3.8
PROV 555,800* 0.90 2.37 0.90 38.1 16.2 18.2 112.5 10.7 4.7 7.9 4.2
Normals 189,500 0.116 1.38 0.50 29.8 4.8 3.1 53.8 4.0 2.8 6.1 3.8
395,300 0.300 1.86 0.74 44.5 8.5 7.2 86.8 6.4 4.6 9.3 4.8
*Value corresponding to size determination. Average count during survival study w
as 294,100.
Cases 6 and 7 had severe dysthrombocytoiesis associated with leukemia or
marrow abnormalities. Case 6 suffered from refractory anemia requiring
monthly transfusions, and case 7 had chronic myelogenous leukemia. In both
patients, normal to elevated platelet counts and increased thrombocytocrit
were associated with macrothrombocytosis and normal life span and age
(Table 2).
DISCUSSION
The tests for lognormality used in this study included analyses of platelet
size distribution by two graphic methods, relating either the differences in log-
frequencies (Fig. 2) or the cumulative frequencies (Fig. 3) to the logarithms of
platelet size. Combined with electronic measurements made on approximately
100,000 elements, the latter method was the most sensitive for the subpopula-
tion smaller than 22-27 cu ￿.zm, since it could detect an increase in the percent-
age of large platelets (more than 13 cu ￿tm) from 12.1% to 23.8%. Furthermore,
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microscopic measurements made on whole-blood smears, although less sensi-
tive, demonstrated that no element was omitted from the distributions and that
the whole-blood curves were similar to those recorded from the corresponding
PRP.
Both microscopic determinations of suspended and smeared platelets and
electronic measurements performed with various Coulter aperture tubes and
cell concentrations and shapes indicated that the diameter (after sphering),
surface (in smeared cells), and volume of normal platelets are lognormally dis-
tributed. In fact, lognormality is characteristic of all platelet size parameters so
far studied, including volume,2’4’29’41’42 dry weight,43 computed cross-sectional
area or diameter, and diameter or surface determined on smears,23’42 These re-
sults conform to the theorem stating that lognormality is preserved when the
variable is multiplied by a constant factor or elevated at a constant, even frac-
tionary power.35
Because the curves obtained in thrombocytopenic patients were often con-
taminated by red cell or background pulses and since the extrapolation used to
calculate the total count was only an approximation, the results of probit plots
in hyperdestruction could not be evaluated with as much confidence as those
from normal subjects. Nearly all curves, however, were compatible with a log-
normal distribution, as were the graphs relating the differences in logfre-
quencies to the logvolumes. Lognormality of platelet volumes was also sug-
gested by measurements made on the young cohort released during the
regeneration phase after platelet depletion.2 These results made it possible to
apply the same general analysis to most platelet curves, using the mean and
standard deviation of logvolumes as primary size indices, from which all other
values could be calculated. The advantages of this mathematical treatment were
the absence of background or red cell interference and the satisfactory accuracy
and reproducibility of the estimated parameters (Table 1).
The fact that platelet populations less than 3-10 hr old already have a log-
normal distribution of volumes indicates that the shape of the PVD is deter-
mined either during thrombocytopoiesis or shortly after platelet release, and
suggests that aging in the circulation does not alter the shape properties of the
PVD. In addition, macrothrombocytosis does exist in cases where the age dis-
tribution of circulating platelets is normal. Examples of this situation are
Mediterranean macroth rom bocytosis and various dysthrombocytopoieses asso-
ciated with leukemia or refractory anemia (Table 2). Similar results have previ-
ously been obtained in some hereditary macrothrombocytopenias’5’2￿26 in-
cluding the May-Hegglin anomaly.4’27 Finally, if macrothrombocytosis in
hyperdestruction is due only to the young age of the circulating population, a
decreased dispersion of volumes should be obtained, since young platelets
have a much smaller age heterogeneity than do normal populations containing
cells of all ages. The results shown in Fig. 5 indicate that, on the contrary,
platelet size is not only increased but is more heterogeneous in hyperdestruc-
tion. In the latter situation, small platelets, as well as large ones, are present.
Although this conclusion does not exclude the possibility that some decrease in
size occurs during aging in the circulation, it demonstrates that such a phe-
nomenon cannot alone provide an adequate explanation for the genesis of
macrothrombocytosis and that thrombocytopoiesis must play a major role.
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The genesis of lognormal distributions has been extensively studied in the
field of small particles.35 Such distributions are produced if the variation in
size at each step of the formation of the particle is a random proportion of the
size reached at the preceding step. This process explains the lognormal distri-
bution ofsmall particles resulting from a multistep fragmentation￿ or growth45
of another particle. Considering that platelets are released as a result of pro-
gressive growth and fragmentation of megakaryocytes, one may explain the
genesis of platelet size curves by postulating that the mean and standard devia-
tion of platelet volumes are determined essentially by the combined rates of
growth and demarcation of the platelet territories. This model, which is pre-
sented in mathematical terms in the appendix, might conceivably explain the
increased mean and standard deviation of platelet volumes occurring in hyper-
destruction as a result of stimulated synthesis of platelet constituents per plate-
let territory or of depressed membrane demarcation or both. For this reason,
the increase in size,2’9’21’23 density,7’9 protein, phospholipid, and cholesterol22
found in young platelets released after platelet depletion may depend more on
thrombopoietic alterations than on the young age of the regenerating cells;
such cells may be different from physiologic young platelets. Also in accordance
with the model is the syndrome of increased platelet size, generally reduced
platelet count, and normal thrombocytocrit recorded in Mediterranean macro-
thrombocytosis42 (Table 2) and recently reported in the May-Hegglin anom-
aly.4’27 This syndrome is best explained by diminished membrane demarcation
in megakaryocytes.4’27 Finally, ultrastructural studies demonstrate that, in leu-
kemia or refractory anemia, micromegakaryocytes with heterogeneous or
deficient demarcation can produce highly heterogeneous platelets including
macroth rom bocytes.￿
The role of other factors in determining platelet size cannot be excluded.
Microthrombocytosis has been found in iron deficiency ‘￿ and the Wiskott-
Aldrich syndrome)5￿8 Megaloblastosis without thrombocytopenia is not ac-
companied by macrothrombocytosis.39 The role of the spleen is still unclear,
although splenectomized human subjects39 or dogs’s have normal platelet size
distributions. Finally, as stated above, this study cannot completely exclude
that a distinct population of large, young platelets has not been detected be-
cause of imperfect electronic and/or mathematical separation of erythrocytes or
insufficient sensitivity of graphic analyses. However, the evidence for such a
population is minimal. The large elements ranging from 13 to 27 cu j.￿m are well
accounted for by the tail of a continuous, unimodal, lognormal distribution.
The recently demonstrated loss of membrane labeling with aging47 does not
prove net loss of membrane, since label elution and/or concomitant membrane
synthesis have not been disproved. Furthermore, loss of membrane would not
necessarily indicate decrease in volume, as is well known from the example of
erythrocyte spherocytes. Finally, contradictory results have been obtained when
platelet specific activity in various density fractions is measured sequentially
after injection of 75Se-selenomethionine-48’49 or 51Cr-chromate-labeled platelets.49
The model presented provides a new interpretation of the origin of platelet
heterogeneity. In a given subject, large platelets may be produced by those
megakaryocyte territories which, by chance, have had the highest combined rate
of growth and demarcation. If the growth rate is a significant fraction of the
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combined rate, large platelets should be expected to show signs of increased
growth other than their large size. Their greater metabolic and functional prop-
erties per unit volume3’7’0 could also be explained on this basis. In other words,
the experimental results and the model presented are compatible with the thesis
of one single platelet population, showing, for probabilistic reasons, a high
correlation between apparently distinct properties. Platelets may in fact have
little other heterogeneity than that. inherent in the concept of population,
wherein the properties of each single element result from the multiplicative
effects of a large number of random variations.
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APPENDIX
Megakaryocyte maturation is conceived as a sequence of n growth and demarcation steps.
Starting with a potential volume X0, each future platelet territory has a volume X￿ at step j and a
volume X￿ at platelet release, It is postulated that the volume variation due to growth is, at each
step, a random proportion of the volume reached at the preceding step35 so that
Xj-Xj-i
=
where the t3 are random and mutually independent; moreover in the simplest cases they are
also independent from the A’￿,35
It is similarly postulated that the volume variation due to territory demarcation is, at each
step, a random proportion s￿ of the previous value of the volume.43 The ii,, are random and
mutually independent, independent from the (￿ and, in the simplest case, from the Xj,.
The net relative volume variation at each step is then w3 = + i￿, where the w1 have the same
properties of independence as the e￿. The mean (rn,.,1) and standard deviation (a￿￿) of the w1
can be expressed as per cent volume increase during the step considered.
If the volume variation at each step is small, it follows that
= - f ￿ = In X￿ - In X0
and
In X,, = In X0 + w￿ + “2 + U)3 ￿ + w,,.
From the central limit theorem, In X￿ is asymtotically normally distributed with mean
In X0 + ￿m. and standard deviation (￿￿2)i/235
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